BVF PARTNERS L P/IL Insider Trading $XENE Xenon Pharmaceuticals Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BVF PARTNERS L P/IL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).

Over the past year BVF PARTNERS L P/IL has been an insider in 11 companies. The total value of shares held by BVF PARTNERS L P/IL in these companies amounts to $226,487,611.

BVF PARTNERS L P/IL 10% Owner
ALPINE IMMUNE SCIENCES, INC.
10% Owner
ARQULE INC
10% Owner
Calithera Biosciences, Inc.
Capstone Therapeutics Corp.
ChemoCentryx, Inc.
10% Owner
CONCERT PHARMACEUTICALS, INC.
Director, 10% Owner
CTI BIOPHARMA CORP
CYTOKINETICS INC
Eledon Pharmaceuticals, Inc.
FIVE PRIME THERAPEUTICS, INC.
10% Owner
GLYCOMIMETICS INC
IDEAYA Biosciences, Inc.
10% Owner
IMMUNE DESIGN CORP.
10% Owner
INFINITY PHARMACEUTICALS, INC.
Director
Kymera Therapeutics, Inc.
10% Owner
Merus N.V.
Director
Olema Pharmaceuticals, Inc.
10% Owner
PIERIS PHARMACEUTICALS, INC.
10% Owner
Principia Biopharma Inc.
Director
Rain Therapeutics Inc.
10% Owner
Syndax Pharmaceuticals Inc
10% Owner
Xenon Pharmaceuticals Inc.
Director, 10% Owner
XOMA Corp
$ 226487611 The total value of shares held by BVF PARTNERS L P/IL
Insider Rank

BVF PARTNERS L P/IL ranks 211 out of 350,000 insiders. Go to Insider Ranking to see more.

BVF PARTNERS L P/IL in Xenon Pharmaceuticals Inc.

Trading Symbol: XENE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 336,468 shares
Current Value: $2,759,038
Latest Transaction: Mar 29 2018
$XENE Market Capitalization: $145.83M
$XENE Previous Close: $8.20

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL

Last 3 Months Overview:
Buy: 28x
Sell: 3x
Shares Bought: 551,180
Shares Sold: 2,437,000
Share Difference: -1,885,820
Value Difference: -$2,048,418

Latest Insider Trading Transactions of BVF PARTNERS L P/IL in Xenon Pharmaceuticals Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 29 2018XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerOption ExerciseJ0.00238,0000238,000
Mar 29 2018XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerOption ExerciseJ0.00861,0000861,000
Mar 29 2018XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerOption ExerciseJ0.001,338,00001,338,000
Mar 29 2018XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerSellJ0.00238,000059,464297.5 K to 59.5 K (-80.01 %)
Mar 29 2018XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerSellJ0.00861,0000216,6941.1 M to 216.7 K (-79.89 %)
Mar 29 2018XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerSellJ0.001,338,0000336,4681.7 M to 336.5 K (-79.91 %)
Aug 16 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP2.417,42917,9201,077,6941.1 M to 1.1 M (+0.69 %)
Aug 16 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP2.4111,42927,5691,674,4681.7 M to 1.7 M (+0.69 %)
Aug 16 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP2.7013,33736,0581,070,2651.1 M to 1.1 M (+1.26 %)
Aug 16 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP2.7028,00775,7201,663,0391.6 M to 1.7 M (+1.71 %)
Jun 29 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP4.008,49633,984297,464289 K to 297.5 K (+2.94 %)
Jun 29 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP4.0030,170120,6801,056,9281 M to 1.1 M (+2.94 %)
Jun 29 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP4.0046,795187,1801,635,0321.6 M to 1.6 M (+2.95 %)
Jun 23 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP4.008543,416288,968288.1 K to 289 K (+0.30 %)
Jun 23 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP4.002,88411,5361,026,7581 M to 1 M (+0.28 %)
Jun 23 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP4.004,52518,1001,588,2371.6 M to 1.6 M (+0.29 %)
Jun 23 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP4.001,3625,448288,114286.8 K to 288.1 K (+0.47 %)
Jun 23 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP4.004,40617,6241,023,8741 M to 1 M (+0.43 %)
Jun 23 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP4.006,38025,5201,583,7121.6 M to 1.6 M (+0.40 %)
Jun 19 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.853571,374286,752286.4 K to 286.8 K (+0.12 %)
Jun 19 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.851,2714,8931,019,4681 M to 1 M (+0.12 %)
Jun 19 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.851,9677,5731,577,3321.6 M to 1.6 M (+0.12 %)
Jun 19 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.851,0644,096286,395285.3 K to 286.4 K (+0.37 %)
Jun 19 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.853,87314,9111,018,1971 M to 1 M (+0.38 %)
Jun 19 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.856,09723,4731,575,3651.6 M to 1.6 M (+0.39 %)
Jun 19 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.841,1604,451285,331284.2 K to 285.3 K (+0.41 %)
Jun 19 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.843,84514,7531,014,3241 M to 1 M (+0.38 %)
Jun 19 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.846,77425,9921,569,2681.6 M to 1.6 M (+0.43 %)
Jun 08 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.8520,59479,312284,171263.6 K to 284.2 K (+7.81 %)
Jun 08 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.8573,749284,0221,010,479936.7 K to 1 M (+7.87 %)
Jun 08 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.85113,446436,9031,562,4941.4 M to 1.6 M (+7.83 %)
Jun 08 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.759133,424263,577262.7 K to 263.6 K (+0.35 %)
Jun 08 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.7553,260199,725936,730883.5 K to 936.7 K (+6.03 %)
Jun 08 2017XENEXenon Pharmaceutic ...BVF PARTNERS L P/IL10% OwnerBuyP3.7596,736362,7601,449,0481.4 M to 1.4 M (+7.15 %)

Page:   1